| Popis: |
Long-term complications following COVID-19 are common in hospitalised patients, but the spectrum of symptoms in milder cases remains unclear. In a Norwegian prospective cohort study of 312 patients, 61% of COVID-19 patients (247 home-isolated and 65 hospitalised) had persistent symptoms at six months, most commonly fatigue (37%), impaired concentration (26%), disturbed smell and/or taste (25%), memory loss (24%) and dyspnoea (21%). In young home-isolated adults, aged 16–30, 52% had symptoms at six months, with fatigue (21%), dyspnoea (13%), impaired concentration (13%) and memory loss (11%) posing particular challenges. Pre-existing chronic lung disease and high convalescent antibody titres predicted persistent symptoms, particularly fatigue. Our finding that young, home-isolated adults with mild COVID-19 are at risk of long-lasting dyspnoea and cognitive symptoms highlights the importance of infection control measures, such as vaccination. |
